The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis

Actas Dermosifiliogr. 2017 Nov;108(9):865-866. doi: 10.1016/j.ad.2017.04.007. Epub 2017 Jun 3.

[Article in English, Spanish]

Authors

D Morgado-Carrasco¹, X Fustà-Novell¹, J Riera Monroig¹, J M Mascaró Galy²

Affiliations

¹ Servicio de Dermatología, Hospital Clínic, Universitat de Barcelona, Barcelona, España.
² Servicio de Dermatología, Hospital Clínic, Universitat de Barcelona, Barcelona, España. Electronic address: [email protected].

PMID: 28583269
DOI: 10.1016/j.ad.2017.04.007

No abstract available

Keywords: METOP; Methotrexate; Metotrexato; Psoriasis; Subcutaneous; Subcutáneo.

MeSH terms

Dermatologic Agents / administration & dosage*
Humans
Injections, Subcutaneous
Methotrexate / administration & dosage*
Psoriasis / drug therapy*
Randomized Controlled Trials as Topic

Substances

Dermatologic Agents
Methotrexate